Rapid next-generation sequencing aids in diagnosis of transient abnormal myelopoiesis in a phenotypically normal newborn

Rahela Aziz-Bose; Franziska Wachter; Roberto Chiarle; Neal I Lindeman; Annette S Kim; Barbara A Degar; Kimberly Davies; Yana Pikman

doi:10.1182/bloodadvances.2021006865

Rapid next-generation sequencing aids in diagnosis of transient abnormal myelopoiesis in a phenotypically normal newborn

Blood Adv. 2022 May 10;6(9):2893-2896. doi: 10.1182/bloodadvances.2021006865.

Authors

Rahela Aziz-Bose^{1

2

3}, Franziska Wachter^{1

2

3}, Roberto Chiarle^{2

4}, Neal I Lindeman^{2

5}, Annette S Kim^{2

5}, Barbara A Degar^{1

2

3}, Kimberly Davies^{1

2

3}, Yana Pikman^{1

2

3}

Affiliations

¹ Department of Pediatric Oncology, Dana-Farber Cancer Institute, Boston, MA.
² Harvard Medical School, Boston, MA.
³ Division of Hematology/Oncology, Boston Children's Hospital, Boston, MA.
⁴ Department of Pathology, Boston Children's Hospital, Boston, MA; and.
⁵ Department of Pathology, Brigham and Women's Hospital, Boston, MA.

No abstract available

Publication types

Research Support, N.I.H., Extramural
Research Support, Non-U.S. Gov't

MeSH terms

Down Syndrome*
High-Throughput Nucleotide Sequencing
Humans
Infant, Newborn
Leukemoid Reaction*

Supplementary concepts

Myeloproliferative Syndrome, Transient

Publication types

MeSH terms

Supplementary concepts

Grants and funding